Enanta Pharmaceuticals
ENTA
#8288
Rank
โ‚ฌ0.29 B
Marketcap
10,07ย โ‚ฌ
Share price
-2.18%
Change (1 day)
1.11%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -โ‚ฌ43.27 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ65.25 Million. In 2025 the company made an earning of -โ‚ฌ57.4 Million, an increase over its 2024 earnings that were of -โ‚ฌ87.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ43.27 Million-24.62%
2025 -โ‚ฌ57.4 Million-34.07%
2024 -โ‚ฌ87.07 Million-23.87%
2023 -โ‚ฌ0.12 Billion4.39%
2022 -โ‚ฌ0.11 Billion-4.4%
2021 -โ‚ฌ0.12 Billion91.12%
2020 -โ‚ฌ59.97 Million-407.13%
2019 โ‚ฌ19.52 M-78.63%
2018 โ‚ฌ91.37 M117.97%
2017 โ‚ฌ41.91 M-574.65%
2016 -โ‚ฌ8.84 Million-110.83%
2015 โ‚ฌ81.56 M-4.5%
2014 โ‚ฌ85.4 M-638.53%
2013 -โ‚ฌ15.86 Million-137.98%
2012 โ‚ฌ41.75 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ16.80 B-37,381.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ11.34 B-25,277.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚ฌ11.50 B-25,618.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.09 B-9,183.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.03 B-13,488.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.17 B-22,666.96%๐Ÿ‡บ๐Ÿ‡ธ USA